
    
      Eligible subjects will undergo either an office-based or operating room-based procedure or
      surgery. The approximately 620 subjects will be randomized in a 2:2:1 fashion to one of the
      three treatment groups (248 subjects randomized to the Cocaine HCl 4% solution, 248 subjects
      randomized to the Cocaine HCl 10%, and 124 subjects randomized to the placebo solution)
      pre-procedure and given one application of the assigned test product with Von Frey filament
      testing occurring after application.
    
  